Liquidia (LQDA) Competitor Comparison
We are evaluating the key criteria listed to compare Liquidia (LQDA) against its competitors in the Biotechnology industry.
Market Capitalization
122 / 368Gross Profits
95 / 278Total Revenue
165 / 300EBITDA
138 / 337Free Cashflow
182 / 352Quick Ratio
142 / 357Earnings per Share
180 / 359Dividend yield
0 / 6Total Cash
234 / 358Performance 3 years
32 / 368Performance 5 years
55 / 368Performance 10 years
112 / 368Linearity 3 years
246 / 368Linearity 5 years
330 / 368Linearity 10 years
3 / 368Total Rank
183 / 368Dividend Rank
190 / 368Valuation Rank
315 / 368Piotroski Rank
156 / 368Muliplier Rank
143 / 368Market Capitalization - LQDA ranking 122 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.